Clinical trial

Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow

NCT00811850

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE4

Study timeline

Study start (unknown)2008-12-01Date precision: month

Registry last updated2019-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solutionDRUG

fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solutionDRUG

Sponsors & collaborators

Allerganlead sponsor

Mapped research locations

IndianapolisIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00811850 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.